Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout

Va­lo Health, the well-fund­ed com­pu­ta­tion­al drug dis­cov­ery and de­vel­op­ment start­up launched by Flag­ship Pi­o­neer­ing, lost its in­ter­im CEO less than a year af­ter he took …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.